These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 25640208)

  • 1. What goes up must come down: biomarkers and novel biologicals in severe asthma.
    Hilvering B; Pavord ID
    Clin Exp Allergy; 2015 Jul; 45(7):1162-9. PubMed ID: 25640208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Therapy for Severe Asthma: Identifying the Right Patients.
    Low K; Bardin PG
    Mol Diagn Ther; 2017 Jun; 21(3):235-247. PubMed ID: 28044257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Biologics in Severe Asthma.
    Pavord ID; Hilvering B; Shrimanker R
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.
    Bagnasco D; Ferrando M; Varricchi G; Passalacqua G; Canonica GW
    Int Arch Allergy Immunol; 2016; 170(2):122-31. PubMed ID: 27637004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient stratification and the unmet need in asthma.
    Swedin L; Saarne T; Rehnberg M; Glader P; Niedzielska M; Johansson G; Hazon P; Catley MC
    Pharmacol Ther; 2017 Jan; 169():13-34. PubMed ID: 27373855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different endotypes and phenotypes drive the heterogeneity in severe asthma.
    McDowell PJ; Heaney LG
    Allergy; 2020 Feb; 75(2):302-310. PubMed ID: 31267562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies for the treatment of refractory asthma.
    Hambly N; Nair P
    Curr Opin Pulm Med; 2014 Jan; 20(1):87-94. PubMed ID: 24275927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future biologic therapies in asthma.
    Quirce S; Bobolea I; Domínguez-Ortega J; Barranco P
    Arch Bronconeumol; 2014 Aug; 50(8):355-61. PubMed ID: 24685200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes/endotypes-driven treatment in asthma.
    Braido F; Tiotiu A; Kowal K; Mihaicuta S; Novakova P; Oguzulgen IK
    Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):184-189. PubMed ID: 29601354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the interleukin pathway in the treatment of asthma.
    Chung KF
    Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum periostin: a novel biomarker for asthma management.
    Matsumoto H
    Allergol Int; 2014 Jun; 63(2):153-60. PubMed ID: 24759559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies for the treatment of asthma.
    Catley MC; Coote J; Bari M; Tomlinson KL
    Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical phenotypes of asthma.
    Bradding P; Green RH
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):54-9. PubMed ID: 19907311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
    De Ferrari L; Chiappori A; Bagnasco D; Riccio AM; Passalacqua G; Canonica GW
    Expert Rev Respir Med; 2016; 10(1):29-38. PubMed ID: 26566089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From phenotypes to endotypes to asthma treatment.
    Agache IO
    Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):249-56. PubMed ID: 23587683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.